Giallongo C - Search Results

1

The Role of Inflammation and Inflammasome in Myeloproliferative Disease.

Longhitano L, Li Volti G, Giallongo C, Spampinato M, Barbagallo I, Di Rosa M, Romano A, Avola R, Tibullo D, Palumbo GA. Longhitano L, et al. Among authors: giallongo c. J Clin Med. 2020 Jul 22;9(8):2334. doi: 10.3390/jcm9082334. J Clin Med. 2020. PMID: 32707883 Free PMC article. Review.

2

A cytoprotective role for the heme oxygenase-1/CO pathway during neural differentiation of human mesenchymal stem cells.

Barbagallo I, Tibullo D, Di Rosa M, Giallongo C, Palumbo GA, Raciti G, Campisi A, Vanella A, Green CJ, Motterlini R. Barbagallo I, et al. Among authors: giallongo c. J Neurosci Res. 2008 Jul;86(9):1927-35. doi: 10.1002/jnr.21660. J Neurosci Res. 2008. PMID: 18381758

3

Effects of imatinib mesylate in osteoblastogenesis.

Tibullo D, Giallongo C, La Cava P, Berretta S, Stagno F, Chiarenza A, Conticello C, Palumbo GA, Di Raimondo F. Tibullo D, et al. Among authors: giallongo c. Exp Hematol. 2009 Apr;37(4):461-8. doi: 10.1016/j.exphem.2008.12.008. Exp Hematol. 2009. PMID: 19302920 Free article.

4

Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias.

Stagno F, Vigneri P, Del Fabro V, Stella S, Restuccia N, Giallongo C, Massimino M, Berretta S, Pennisi MS, Tibullo D, Tirrò E, Buscarino C, Messina A, Di Raimondo F. Stagno F, et al. Among authors: giallongo c. Acta Oncol. 2010;49(1):109-10. doi: 10.3109/02841860903302913. Acta Oncol. 2010. PMID: 19842797 No abstract available.

5

Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation.

Barbagallo I, Vanella A, Peterson SJ, Kim DH, Tibullo D, Giallongo C, Vanella L, Parrinello N, Palumbo GA, Di Raimondo F, Abraham NG, Asprinio D. Barbagallo I, et al. Among authors: giallongo c. J Bone Miner Metab. 2010 May;28(3):276-88. doi: 10.1007/s00774-009-0134-y. Epub 2009 Nov 19. J Bone Miner Metab. 2010. PMID: 19924377 Free PMC article.

6

Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells.

Giallongo C, La Cava P, Tibullo D, Parrinello N, Barbagallo I, Del Fabro V, Stagno F, Conticello C, Romano A, Chiarenza A, Palumbo GA, Di Raimondo F. Giallongo C, et al. Eur J Haematol. 2011 Mar;86(3):216-25. doi: 10.1111/j.1600-0609.2010.01570.x. Epub 2011 Feb 8. Eur J Haematol. 2011. PMID: 21198861

7

Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors.

Tibullo D, Barbagallo I, Giallongo C, La Cava P, Branca A, Conticello C, Stagno F, Chiarenza A, Palumbo GA, Di Raimondo F. Tibullo D, et al. Among authors: giallongo c. Hematol Oncol. 2012 Mar;30(1):27-33. doi: 10.1002/hon.988. Epub 2011 May 5. Hematol Oncol. 2012. PMID: 21544849

8

BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint.

Giallongo C, Tibullo D, La Cava P, Branca A, Parrinello N, Spina P, Stagno F, Conticello C, Chiarenza A, Vigneri P, Palumbo GA, Di Raimondo F. Giallongo C, et al. Acta Haematol. 2011;126(4):205-10. doi: 10.1159/000329911. Epub 2011 Sep 16. Acta Haematol. 2011. PMID: 21934293

9

Nuclear translocation of heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells.

Tibullo D, Barbagallo I, Giallongo C, La Cava P, Parrinello N, Vanella L, Stagno F, Palumbo GA, Li Volti G, Di Raimondo F. Tibullo D, et al. Among authors: giallongo c. Curr Pharm Des. 2013;19(15):2765-70. doi: 10.2174/1381612811319150012. Curr Pharm Des. 2013. PMID: 23092325

10

SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation.

Giallongo C, La Cava P, Tibullo D, Barbagallo I, Parrinello N, Cupri A, Stagno F, Consoli C, Chiarenza A, Palumbo GA, Di Raimondo F. Giallongo C, et al. BMC Cancer. 2013 Feb 5;13:60. doi: 10.1186/1471-2407-13-60. BMC Cancer. 2013. PMID: 23383963 Free PMC article.

11

Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients.

Giallongo C, Parrinello N, Tibullo D, La Cava P, Romano A, Chiarenza A, Barbagallo I, Palumbo GA, Stagno F, Vigneri P, Di Raimondo F. Giallongo C, et al. PLoS One. 2014 Jul 11;9(7):e101848. doi: 10.1371/journal.pone.0101848. eCollection 2014. PLoS One. 2014. PMID: 25014230 Free PMC article.

12

Myeloid derived suppressor cells in chronic myeloid leukemia.

Giallongo C, Parrinello N, Brundo MV, Raccuia SA, Di Rosa M, La Cava P, Tibullo D. Giallongo C, et al. Front Oncol. 2015 May 15;5:107. doi: 10.3389/fonc.2015.00107. eCollection 2015. Front Oncol. 2015. PMID: 26029664 Free PMC article. Review.

13

Clinical Impact of the Immunome in Lymphoid Malignancies: The Role of Myeloid-Derived Suppressor Cells.

Vetro C, Romano A, Ancora F, Coppolino F, Brundo MV, Raccuia SA, Puglisi F, Tibullo D, La Cava P, Giallongo C, Parrinello NL. Vetro C, et al. Among authors: giallongo c. Front Oncol. 2015 May 21;5:104. doi: 10.3389/fonc.2015.00104. eCollection 2015. Front Oncol. 2015. PMID: 26052505 Free PMC article. Review.

14

Modulation of extracellular signal-related kinase, cyclin D1, glial fibrillary acidic protein, and vimentin expression in estradiol-pretreated astrocyte cultures treated with competence and progression growth factors.

Bramanti V, Grasso S, Tibullo D, Giallongo C, Raciti G, Viola M, Avola R. Bramanti V, et al. Among authors: giallongo c. J Neurosci Res. 2015 Sep;93(9):1378-87. doi: 10.1002/jnr.23606. Epub 2015 Jun 6. J Neurosci Res. 2015. PMID: 26053243

15

Neuroactive molecules and growth factors modulate cytoskeletal protein expression during astroglial cell proliferation and differentiation in culture.

Bramanti V, Grasso S, Tibullo D, Giallongo C, Pappa R, Brundo MV, Tomassoni D, Viola M, Amenta F, Avola R. Bramanti V, et al. Among authors: giallongo c. J Neurosci Res. 2016 Jan;94(1):90-8. doi: 10.1002/jnr.23678. Epub 2015 Oct 15. J Neurosci Res. 2016. Retraction in: J Neurosci Res. 2025 Apr;103(4):e70036. doi: 10.1002/jnr.70036. PMID: 26469526 Retracted.

16

Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells.

Tibullo D, Di Rosa M, Giallongo C, La Cava P, Parrinello NL, Romano A, Conticello C, Brundo MV, Saccone S, Malaguarnera L, Di Raimondo F. Tibullo D, et al. Among authors: giallongo c. Front Pharmacol. 2015 Oct 14;6:226. doi: 10.3389/fphar.2015.00226. eCollection 2015. Front Pharmacol. 2015. PMID: 26528182 Free PMC article.

17

Heme oxygenase-1 nuclear translocation regulates bortezomibinduced cytotoxicity and mediates genomic instability in myeloma cells.

Tibullo D, Barbagallo I, Giallongo C, Vanella L, Conticello C, Romano A, Saccone S, Godos J, Di Raimondo F, Li Volti G. Tibullo D, et al. Among authors: giallongo c. Oncotarget. 2016 May 17;7(20):28868-80. doi: 10.18632/oncotarget.7563. Oncotarget. 2016. PMID: 26930712 Free PMC article.

18

Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC).

Giallongo C, Tibullo D, Parrinello NL, La Cava P, Di Rosa M, Bramanti V, Di Raimondo C, Conticello C, Chiarenza A, Palumbo GA, Avola R, Romano A, Di Raimondo F. Giallongo C, et al. Oncotarget. 2016 Dec 27;7(52):85764-85775. doi: 10.18632/oncotarget.7969. Oncotarget. 2016. PMID: 26967390 Free PMC article.

19

Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients.

Giallongo C, Romano A, Parrinello NL, La Cava P, Brundo MV, Bramanti V, Stagno F, Vigneri P, Chiarenza A, Palumbo GA, Tibullo D, Di Raimondo F. Giallongo C, et al. PLoS One. 2016 Jul 8;11(7):e0158392. doi: 10.1371/journal.pone.0158392. eCollection 2016. PLoS One. 2016. PMID: 27391078 Free PMC article.

20

The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma.

Romano A, Parrinello NL, Vetro C, Tibullo D, Giallongo C, La Cava P, Chiarenza A, Motta G, Caruso AL, Villari L, Tripodo C, Cosentino S, Ippolito M, Consoli U, Gallamini A, Pileri S, Di Raimondo F. Romano A, et al. Among authors: giallongo c. Oncotarget. 2016 Oct 11;7(41):67333-67346. doi: 10.18632/oncotarget.12024. Oncotarget. 2016. PMID: 27637084 Free PMC article.

21

Antiproliferative and Antiangiogenic Effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM).

Tibullo D, Caporarello N, Giallongo C, Anfuso CD, Genovese C, Arlotta C, Puglisi F, Parrinello NL, Bramanti V, Romano A, Lupo G, Toscano V, Avola R, Brundo MV, Di Raimondo F, Raccuia SA. Tibullo D, et al. Among authors: giallongo c. Nutrients. 2016 Oct 1;8(10):611. doi: 10.3390/nu8100611. Nutrients. 2016. PMID: 27706074 Free PMC article.

22

The Heme Oxygenase System in Hematological Malignancies.

Li Volti G, Tibullo D, Vanella L, Giallongo C, Di Raimondo F, Forte S, Di Rosa M, Signorelli SS, Barbagallo I. Li Volti G, et al. Among authors: giallongo c. Antioxid Redox Signal. 2017 Aug 20;27(6):363-377. doi: 10.1089/ars.2016.6735. Epub 2017 May 19. Antioxid Redox Signal. 2017. PMID: 28257621 Review.

23

Proteomic Analysis Reveals Autophagy as Pro-Survival Pathway Elicited by Long-Term Exposure with 5-Azacitidine in High-Risk Myelodysplasia.

Romano A, Giallongo C, La Cava P, Parrinello NL, Chiechi A, Vetro C, Tibullo D, Di Raimondo F, Liotta LA, Espina V, Palumbo GA. Romano A, et al. Among authors: giallongo c. Front Pharmacol. 2017 Apr 26;8:204. doi: 10.3389/fphar.2017.00204. eCollection 2017. Front Pharmacol. 2017. PMID: 28491035 Free PMC article.

24

Effect of Lipoic Acid on the Biochemical Mechanisms of Resistance to Bortezomib in SH-SY5Y Neuroblastoma Cells.

Tibullo D, Giallongo C, Puglisi F, Tomassoni D, Camiolo G, Cristaldi M, Brundo MV, Anfuso CD, Lupo G, Stampone T, Li Volti G, Amenta F, Avola R, Bramanti V. Tibullo D, et al. Among authors: giallongo c. Mol Neurobiol. 2018 Apr;55(4):3344-3350. doi: 10.1007/s12035-017-0575-6. Epub 2017 May 11. Mol Neurobiol. 2018. PMID: 28497200

25

Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential.

Tibullo D, Li Volti G, Giallongo C, Grasso S, Tomassoni D, Anfuso CD, Lupo G, Amenta F, Avola R, Bramanti V. Tibullo D, et al. Among authors: giallongo c. Inflamm Res. 2017 Nov;66(11):947-959. doi: 10.1007/s00011-017-1079-6. Epub 2017 Jul 4. Inflamm Res. 2017. PMID: 28676917 Review.

26

Antimicrobial and Anti-Proliferative Effects of Skin Mucus Derived from Dasyatis pastinaca (Linnaeus, 1758).

Fuochi V, Li Volti G, Camiolo G, Tiralongo F, Giallongo C, Distefano A, Petronio Petronio G, Barbagallo I, Viola M, Furneri PM, Di Rosa M, Avola R, Tibullo D. Fuochi V, et al. Among authors: giallongo c. Mar Drugs. 2017 Nov 1;15(11):342. doi: 10.3390/md15110342. Mar Drugs. 2017. PMID: 29104260 Free PMC article.

27

Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib.

Giallongo C, Parrinello NL, La Cava P, Camiolo G, Romano A, Scalia M, Stagno F, Palumbo GA, Avola R, Li Volti G, Tibullo D, Di Raimondo F. Giallongo C, et al. J Cell Mol Med. 2018 Feb;22(2):1070-1080. doi: 10.1111/jcmm.13326. Epub 2017 Dec 8. J Cell Mol Med. 2018. PMID: 29218828 Free PMC article.

28

PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy.

Romano A, Parrinello NL, La Cava P, Tibullo D, Giallongo C, Camiolo G, Puglisi F, Parisi M, Pirosa MC, Martino E, Conticello C, Palumbo GA, Di Raimondo F. Romano A, et al. Among authors: giallongo c. Expert Rev Mol Diagn. 2018 Jul;18(7):675-683. doi: 10.1080/14737159.2018.1470929. Epub 2018 May 3. Expert Rev Mol Diagn. 2018. PMID: 29707981

29

Heme Oxygenase Inhibition Sensitizes Neuroblastoma Cells to Carfilzomib.

Barbagallo I, Giallongo C, Volti GL, Distefano A, Camiolo G, Raffaele M, Salerno L, Pittalà V, Sorrenti V, Avola R, Di Rosa M, Vanella L, Di Raimondo F, Tibullo D. Barbagallo I, et al. Among authors: giallongo c. Mol Neurobiol. 2019 Feb;56(2):1451-1460. doi: 10.1007/s12035-018-1133-6. Epub 2018 Jun 10. Mol Neurobiol. 2019. PMID: 29948946

30

α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload.

Camiolo G, Tibullo D, Giallongo C, Romano A, Parrinello NL, Musumeci G, Di Rosa M, Vicario N, Brundo MV, Amenta F, Ferrante M, Copat C, Avola R, Li Volti G, Salvaggio A, Di Raimondo F, Palumbo GA. Camiolo G, et al. Among authors: giallongo c. Int J Mol Sci. 2019 Jan 31;20(3):609. doi: 10.3390/ijms20030609. Int J Mol Sci. 2019. PMID: 30708965 Free PMC article.

31

Immune off-target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma.

Romano A, Parrinello NL, Chiarenza A, Motta G, Tibullo D, Giallongo C, La Cava P, Camiolo G, Puglisi F, Palumbo GA, Di Raimondo F. Romano A, et al. Among authors: giallongo c. Br J Haematol. 2019 May;185(3):468-479. doi: 10.1111/bjh.15801. Epub 2019 Feb 15. Br J Haematol. 2019. PMID: 30768678 Clinical Trial.

32

Biological properties of Cakile maritima Scop. (Brassicaceae) extracts.

Fuochi V, Barbagallo I, Distefano A, Puglisi F, Palmeri R, Di Rosa M, Giallongo C, Longhitano L, Fontana P, Sferrazzo G, Tiralongo F, Raccuia SA, Ronsisvalle S, Li Volti G, Furneri PM, Tibullo D. Fuochi V, et al. Among authors: giallongo c. Eur Rev Med Pharmacol Sci. 2019 Mar;23(5):2280-2292. doi: 10.26355/eurrev_201903_17277. Eur Rev Med Pharmacol Sci. 2019. PMID: 30915777 Free article.

33

Clobetasol Modulates Adult Neural Stem Cell Growth via Canonical Hedgehog Pathway Activation.

Vicario N, Bernstock JD, Spitale FM, Giallongo C, Giunta MAS, Li Volti G, Gulisano M, Leanza G, Tibullo D, Parenti R, Gulino R. Vicario N, et al. Among authors: giallongo c. Int J Mol Sci. 2019 Apr 23;20(8):1991. doi: 10.3390/ijms20081991. Int J Mol Sci. 2019. PMID: 31018557 Free PMC article.

34

Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome.

Bereshchenko O, Lo Re O, Nikulenkov F, Flamini S, Kotaskova J, Mazza T, Le Pannérer MM, Buschbeck M, Giallongo C, Palumbo G, Li Volti G, Pazienza V, Cervinek L, Riccardi C, Krejci L, Pospisilova S, Stewart AF, Vinciguerra M. Bereshchenko O, et al. Among authors: giallongo c. Clin Epigenetics. 2019 Aug 22;11(1):121. doi: 10.1186/s13148-019-0724-z. Clin Epigenetics. 2019. PMID: 31439048 Free PMC article.

35

TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma.

Giallongo C, Tibullo D, Camiolo G, Parrinello NL, Romano A, Puglisi F, Barbato A, Conticello C, Lupo G, Anfuso CD, Lazzarino G, Li Volti G, Palumbo GA, Di Raimondo F. Giallongo C, et al. Cell Death Dis. 2019 Sep 20;10(10):704. doi: 10.1038/s41419-019-1959-5. Cell Death Dis. 2019. PMID: 31541083 Free PMC article.

36

Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma.

Giallongo C, Tibullo D, Camiolo G, Parrinello NL, Romano A, Puglisi F, Barbato A, Conticello C, Lupo G, Anfuso CD, Lazzarino G, Volti GL, Palumbo GA, Di Raimono F. Giallongo C, et al. Cell Death Dis. 2019 Oct 28;10(11):820. doi: 10.1038/s41419-019-2059-2. Cell Death Dis. 2019. PMID: 31659155 Free PMC article.

37

Monocytic Myeloid Derived Suppressor Cells in Hematological Malignancies.

Palumbo GA, Parrinello NL, Giallongo C, D'Amico E, Zanghì A, Puglisi F, Conticello C, Chiarenza A, Tibullo D, Raimondo FD, Romano A. Palumbo GA, et al. Among authors: giallongo c. Int J Mol Sci. 2019 Nov 1;20(21):5459. doi: 10.3390/ijms20215459. Int J Mol Sci. 2019. PMID: 31683978 Free PMC article. Review.

38

Ixazomib Improves Bone Remodeling and Counteracts sonic Hedgehog signaling Inhibition Mediated by Myeloma Cells.

Tibullo D, Longo A, Vicario N, Romano A, Barbato A, Di Rosa M, Barbagallo I, Anfuso CD, Lupo G, Gulino R, Parenti R, Li Volti GL, Palumbo GA, Di Raimondo FD, Giallongo C. Tibullo D, et al. Among authors: giallongo c. Cancers (Basel). 2020 Jan 30;12(2):323. doi: 10.3390/cancers12020323. Cancers (Basel). 2020. PMID: 32019102 Free PMC article.

39

High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling.

Romano A, Parrinello NL, Simeon V, Puglisi F, La Cava P, Bellofiore C, Giallongo C, Camiolo G, D'Auria F, Grieco V, Larocca F, Barbato A, Cambria D, La Spina E, Tibullo D, Palumbo GA, Conticello C, Musto P, Di Raimondo F. Romano A, et al. Among authors: giallongo c. Sci Rep. 2020 Feb 6;10(1):1983. doi: 10.1038/s41598-020-58859-x. Sci Rep. 2020. PMID: 32029833 Free PMC article.

40

Role of 17β-Estradiol on Cell Proliferation and Mitochondrial Fitness in Glioblastoma Cells.

Castracani CC, Longhitano L, Distefano A, Anfuso D, Kalampoka S, La Spina E, Astuto M, Avola R, Caruso M, Nicolosi D, Giallongo C, Tibullo D, Volti GL. Castracani CC, et al. Among authors: giallongo c. J Oncol. 2020 Feb 14;2020:2314693. doi: 10.1155/2020/2314693. eCollection 2020. J Oncol. 2020. PMID: 32148493 Free PMC article.

41

Immunoproteasome Genes Are Modulated in CD34⁺ JAK2^V617F Mutated Cells from Primary Myelofibrosis Patients.

Di Rosa M, Giallongo C, Romano A, Tibullo D, Li Volti G, Musumeci G, Barbagallo I, Imbesi R, Castrogiovanni P, Palumbo GA. Di Rosa M, et al. Among authors: giallongo c. Int J Mol Sci. 2020 Apr 22;21(8):2926. doi: 10.3390/ijms21082926. Int J Mol Sci. 2020. PMID: 32331228 Free PMC article.

42

Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells.

Tibullo D, Giallongo C, Romano A, Vicario N, Barbato A, Puglisi F, Parenti R, Amorini AM, Wissam Saab M, Tavazzi B, Mangione R, Brundo MV, Lazzarino G, Palumbo GA, Volti GL, Raimondo FD, Lazzarino G. Tibullo D, et al. Among authors: giallongo c. Biomolecules. 2020 Apr 30;10(5):696. doi: 10.3390/biom10050696. Biomolecules. 2020. PMID: 32365811 Free PMC article.

43

Proteasome Inhibitors as a Possible Therapy for SARS-CoV-2.

Longhitano L, Tibullo D, Giallongo C, Lazzarino G, Tartaglia N, Galimberti S, Li Volti G, Palumbo GA, Liso A. Longhitano L, et al. Among authors: giallongo c. Int J Mol Sci. 2020 May 20;21(10):3622. doi: 10.3390/ijms21103622. Int J Mol Sci. 2020. PMID: 32443911 Free PMC article. Review.

44

Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy Via STAT3.

Puglisi F, Parrinello NL, Giallongo C, Cambria D, Camiolo G, Bellofiore C, Conticello C, Del Fabro V, Leotta V, Markovic U, Sapienza G, Barbato A, Scalese S, Tibullo D, Brundo MV, Palumbo GA, Di Raimondo F, Romano A. Puglisi F, et al. Among authors: giallongo c. Int J Mol Sci. 2019 Jul 19;20(14):3548. doi: 10.3390/ijms20143548. Int J Mol Sci. 2019. PMID: 32565533 Free PMC article.

45

Inhibition of TLR4 Signaling Affects Mitochondrial Fitness and Overcomes Bortezomib Resistance in Myeloma Plasma Cells.

Giallongo C, Tibullo D, Puglisi F, Barbato A, Vicario N, Cambria D, Parrinello NL, Romano A, Conticello C, Forte S, Parenti R, Amorini AM, Lazzarino G, Li Volti G, Palumbo GA, Di Raimondo F. Giallongo C, et al. Cancers (Basel). 2020 Jul 22;12(8):1999. doi: 10.3390/cancers12081999. Cancers (Basel). 2020. PMID: 32707760 Free PMC article.

46

Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib.

Camiolo G, Barbato A, Giallongo C, Vicario N, Romano A, Parrinello NL, Parenti R, Sandoval JC, García-Moreno D, Lazzarino G, Avola R, Palumbo GA, Mulero V, Li Volti G, Tibullo D, Di Raimondo F. Camiolo G, et al. Among authors: giallongo c. Redox Biol. 2020 Sep;36:101611. doi: 10.1016/j.redox.2020.101611. Epub 2020 Jun 24. Redox Biol. 2020. PMID: 32863212 Free PMC article.

47

Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview.

Barbato A, Scandura G, Puglisi F, Cambria D, La Spina E, Palumbo GA, Lazzarino G, Tibullo D, Di Raimondo F, Giallongo C, Romano A. Barbato A, et al. Among authors: giallongo c. Front Oncol. 2020 Dec 21;10:604143. doi: 10.3389/fonc.2020.604143. eCollection 2020. Front Oncol. 2020. PMID: 33409153 Free PMC article. Review.

48

Focus on Osteosclerotic Progression in Primary Myelofibrosis.

Spampinato M, Giallongo C, Romano A, Longhitano L, La Spina E, Avola R, Scandura G, Dulcamare I, Bramanti V, Di Rosa M, Vicario N, Parenti R, Li Volti G, Tibullo D, Palumbo GA. Spampinato M, et al. Among authors: giallongo c. Biomolecules. 2021 Jan 19;11(1):122. doi: 10.3390/biom11010122. Biomolecules. 2021. PMID: 33477816 Free PMC article. Review.

49

Clobetasol promotes neuromuscular plasticity in mice after motoneuronal loss via sonic hedgehog signaling, immunomodulation and metabolic rebalancing.

Vicario N, Spitale FM, Tibullo D, Giallongo C, Amorini AM, Scandura G, Spoto G, Saab MW, D'Aprile S, Alberghina C, Mangione R, Bernstock JD, Botta C, Gulisano M, Buratti E, Leanza G, Zorec R, Vecchio M, Di Rosa M, Li Volti G, Lazzarino G, Parenti R, Gulino R. Vicario N, et al. Among authors: giallongo c. Cell Death Dis. 2021 Jun 16;12(7):625. doi: 10.1038/s41419-021-03907-1. Cell Death Dis. 2021. PMID: 34135312 Free PMC article.

50

IGFBP-6/sonic hedgehog/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis.

Longhitano L, Tibullo D, Vicario N, Giallongo C, La Spina E, Romano A, Lombardo S, Moretti M, Masia F, Coda ARD, Venuto S, Fontana P, Parenti R, Li Volti G, Di Rosa M, Palumbo GA, Liso A. Longhitano L, et al. Among authors: giallongo c. Aging (Albany NY). 2021 Dec 14;13(23):25055-25071. doi: 10.18632/aging.203779. Epub 2021 Dec 14. Aging (Albany NY). 2021. PMID: 34905501 Free PMC article.

51

Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) Counteracts UV-B Radiation-Induced ROS Formation in Corneal Epithelium.

Maugeri G, D'Amico AG, Giunta S, Giallongo C, Tibullo D, Bucolo C, Saccone S, Federico C, Scollo D, Longo A, Avitabile T, Musumeci G, D'Agata V. Maugeri G, et al. Among authors: giallongo c. Antioxidants (Basel). 2022 Jan 7;11(1):128. doi: 10.3390/antiox11010128. Antioxidants (Basel). 2022. PMID: 35052632 Free PMC article.

52

CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment.

Giallongo C, Dulcamare I, Tibullo D, Del Fabro V, Vicario N, Parrinello N, Romano A, Scandura G, Lazzarino G, Conticello C, Li Volti G, Amorini AM, Musumeci G, Di Rosa M, Polito F, Oteri R, Aguennouz M, Parenti R, Di Raimondo F, Palumbo GA. Giallongo C, et al. Oncogenesis. 2022 Jan 21;11(1):6. doi: 10.1038/s41389-022-00380-z. Oncogenesis. 2022. PMID: 35064098 Free PMC article.

53

TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment.

Scandura G, Giallongo C, Puglisi F, Romano A, Parrinello NL, Zuppelli T, Longhitano L, Giallongo S, Di Rosa M, Musumeci G, Motterlini R, Foresti R, Palumbo GA, Li Volti G, Di Raimondo F, Tibullo D. Scandura G, et al. Among authors: giallongo c, giallongo s. Antioxidants (Basel). 2022 Apr 12;11(4):767. doi: 10.3390/antiox11040767. Antioxidants (Basel). 2022. PMID: 35453452 Free PMC article.

54

IGFBP-6: At the Crossroads of Immunity, Tissue Repair and Fibrosis.

Liso A, Venuto S, Coda ARD, Giallongo C, Palumbo GA, Tibullo D. Liso A, et al. Among authors: giallongo c. Int J Mol Sci. 2022 Apr 14;23(8):4358. doi: 10.3390/ijms23084358. Int J Mol Sci. 2022. PMID: 35457175 Free PMC article. Review.

55

In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection.

Romano A, Parrinello NL, Barchitta M, Manuele R, Puglisi F, Maugeri A, Barbato A, Triolo AM, Giallongo C, Tibullo D, La Ferla L, Botta C, Siragusa S, Iacobello C, Montineri A, Volti GL, Agodi A, Palumbo GA, Di Raimondo F. Romano A, et al. Among authors: giallongo c. Sci Rep. 2022 May 4;12(1):7237. doi: 10.1038/s41598-022-11157-0. Sci Rep. 2022. PMID: 35508575 Free PMC article.

56

Lactate Induces the Expressions of MCT1 and HCAR1 to Promote Tumor Growth and Progression in Glioblastoma.

Longhitano L, Vicario N, Tibullo D, Giallongo C, Broggi G, Caltabiano R, Barbagallo GMV, Altieri R, Baghini M, Di Rosa M, Parenti R, Giordano A, Mione MC, Li Volti G. Longhitano L, et al. Among authors: giallongo c. Front Oncol. 2022 Apr 28;12:871798. doi: 10.3389/fonc.2022.871798. eCollection 2022. Front Oncol. 2022. PMID: 35574309 Free PMC article.

57

Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma.

Longhitano L, Vicario N, Forte S, Giallongo C, Broggi G, Caltabiano R, Barbagallo GMV, Altieri R, Raciti G, Di Rosa M, Caruso M, Parenti R, Liso A, Busi F, Lolicato M, Mione MC, Li Volti G, Tibullo D. Longhitano L, et al. Among authors: giallongo c. Cancer Immunol Immunother. 2023 Jan;72(1):1-20. doi: 10.1007/s00262-022-03215-3. Epub 2022 Jun 3. Cancer Immunol Immunother. 2023. PMID: 35654889 Free PMC article.

58

Correction to: Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma.

Longhitano L, Vicario N, Forte S, Giallongo C, Broggi G, Caltabiano R, Barbagallo GMV, Altieri R, Raciti G, Di Rosa M, Caruso M, Parenti R, Liso A, Busi F, Lolicato M, Mione MC, Li Volti G, Tibullo D. Longhitano L, et al. Among authors: giallongo c. Cancer Immunol Immunother. 2023 Jan;72(1):21. doi: 10.1007/s00262-022-03243-z. Cancer Immunol Immunother. 2023. PMID: 35821528 Free PMC article. No abstract available.

59

Chitinase domain containing 1 increase is associated with low survival rate and M0 macrophages infiltrates in colorectal cancer patients.

Castrogiovanni P, Barbagallo I, Imbesi R, Musumeci G, Sanfilippo C, Broggi G, Caltabiano R, Tibullo D, Giallongo C, Forte S, Li Volti G, Di Rosa M. Castrogiovanni P, et al. Among authors: giallongo c. Pathol Res Pract. 2022 Sep;237:154038. doi: 10.1016/j.prp.2022.154038. Epub 2022 Jul 22. Pathol Res Pract. 2022. PMID: 35932496

60

Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models.

Carota G, Distefano A, Spampinato M, Giallongo C, Broggi G, Longhitano L, Palumbo GA, Parenti R, Caltabiano R, Giallongo S, Di Rosa M, Polosa R, Bramanti V, Vicario N, Li Volti G, Tibullo D. Carota G, et al. Among authors: giallongo c, giallongo s. Antioxidants (Basel). 2022 Aug 18;11(8):1596. doi: 10.3390/antiox11081596. Antioxidants (Basel). 2022. PMID: 36009316 Free PMC article.

61

The Role of Epigenetics in Neuroinflammatory-Driven Diseases.

Giallongo S, Longhitano L, Denaro S, D'Aprile S, Torrisi F, La Spina E, Giallongo C, Mannino G, Lo Furno D, Zappalà A, Giuffrida R, Parenti R, Li Volti G, Tibullo D, Vicario N. Giallongo S, et al. Among authors: giallongo c. Int J Mol Sci. 2022 Dec 2;23(23):15218. doi: 10.3390/ijms232315218. Int J Mol Sci. 2022. PMID: 36499544 Free PMC article. Review.

62

Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting.

Duminuco A, Nardo A, Garibaldi B, Vetro C, Longo A, Giallongo C, Di Raimondo F, Palumbo GA. Duminuco A, et al. Among authors: giallongo c. J Clin Med. 2022 Dec 14;11(24):7418. doi: 10.3390/jcm11247418. J Clin Med. 2022. PMID: 36556033 Free PMC article.

63

Lactate Rewrites the Metabolic Reprogramming of Uveal Melanoma Cells and Induces Quiescence Phenotype.

Longhitano L, Giallongo S, Orlando L, Broggi G, Longo A, Russo A, Caltabiano R, Giallongo C, Barbagallo I, Di Rosa M, Giuffrida R, Parenti R, Li Volti G, Vicario N, Tibullo D. Longhitano L, et al. Among authors: giallongo s, giallongo c. Int J Mol Sci. 2022 Dec 20;24(1):24. doi: 10.3390/ijms24010024. Int J Mol Sci. 2022. PMID: 36613471 Free PMC article.

64

Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma.

Barbato A, Giallongo C, Giallongo S, Romano A, Scandura G, Concetta S, Zuppelli T, Lolicato M, Lazzarino G, Parrinello N, Del Fabro V, Fontana P, Aguennoz M, Li Volti G, Palumbo GA, Di Raimondo F, Tibullo D. Barbato A, et al. Among authors: giallongo c, giallongo s. Cell Prolif. 2023 Apr;56(4):e13388. doi: 10.1111/cpr.13388. Epub 2023 Feb 15. Cell Prolif. 2023. PMID: 36794373 Free PMC article.

65

Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine.

Palumbo GA, Cambria D, La Spina E, Duminuco A, Laneri A, Longo A, Vetro C, Giallongo S, Romano A, Di Raimondo F, Tibullo D, Giallongo C. Palumbo GA, et al. Among authors: giallongo s, giallongo c. Front Oncol. 2023 Feb 14;13:1117815. doi: 10.3389/fonc.2023.1117815. eCollection 2023. Front Oncol. 2023. PMID: 36865808 Free PMC article.

66

Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases.

La Spina E, Giallongo S, Giallongo C, Vicario N, Duminuco A, Parenti R, Giuffrida R, Longhitano L, Li Volti G, Cambria D, Di Raimondo F, Musumeci G, Romano A, Palumbo GA, Tibullo D. La Spina E, et al. Among authors: giallongo s, giallongo c. Front Oncol. 2023 Feb 23;13:1141610. doi: 10.3389/fonc.2023.1141610. eCollection 2023. Front Oncol. 2023. PMID: 36910610 Free PMC article. Review.

67

Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future.

Duminuco A, Nardo A, Giuffrida G, Leotta S, Markovic U, Giallongo C, Tibullo D, Romano A, Di Raimondo F, Palumbo GA. Duminuco A, et al. Among authors: giallongo c. J Clin Med. 2023 Mar 11;12(6):2188. doi: 10.3390/jcm12062188. J Clin Med. 2023. PMID: 36983189 Free PMC article. Review.

68

Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab.

Duminuco A, Romano A, Leotta D, La Spina E, Cambria D, Bulla A, Del Fabro V, Tibullo D, Giallongo C, Palumbo GA, Conticello C, Di Raimondo F. Duminuco A, et al. Among authors: giallongo c. Front Oncol. 2023 Mar 29;13:1157610. doi: 10.3389/fonc.2023.1157610. eCollection 2023. Front Oncol. 2023. PMID: 37064138 Free PMC article.

69

The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors.

Duminuco A, Vetro C, Giallongo C, Palumbo GA. Duminuco A, et al. Among authors: giallongo c. Expert Opin Pharmacother. 2023 Sep-Dec;24(13):1449-1461. doi: 10.1080/14656566.2023.2228695. Epub 2023 Jun 26. Expert Opin Pharmacother. 2023. PMID: 37341682 Review.

70

The Pleiotropic Effects of Fumarate: From Mitochondrial Respiration to Epigenetic Rewiring and DNA Repair Mechanisms.

Giallongo S, Costa F, Longhitano L, Giallongo C, Ferrigno J, Tropea E, Vicario N, Li Volti G, Parenti R, Barbagallo I, Bramanti V, Tibullo D. Giallongo S, et al. Among authors: giallongo c. Metabolites. 2023 Jul 24;13(7):880. doi: 10.3390/metabo13070880. Metabolites. 2023. PMID: 37512586 Free PMC article. Review.

71

Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance.

D'Aprile S, Denaro S, Pavone AM, Giallongo S, Giallongo C, Distefano A, Salvatorelli L, Torrisi F, Giuffrida R, Forte S, Tibullo D, Li Volti G, Magro G, Vicario N, Parenti R. D'Aprile S, et al. Among authors: giallongo s, giallongo c. J Transl Med. 2023 Nov 3;21(1):780. doi: 10.1186/s12967-023-04664-9. J Transl Med. 2023. PMID: 37924062 Free PMC article.

72

Correction: Carota et al. Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models. Antioxidants 2022, 11, 1596.

Carota G, Distefano A, Spampinato M, Giallongo C, Broggi G, Longhitano L, Palumbo GA, Parenti R, Caltabiano R, Giallongo S, Di Rosa M, Polosa R, Bramanti V, Vicario N, Li Volti G, Tibullo D. Carota G, et al. Among authors: giallongo c, giallongo s. Antioxidants (Basel). 2023 Dec 12;12(12):2099. doi: 10.3390/antiox12122099. Antioxidants (Basel). 2023. PMID: 38136252 Free PMC article.

73

Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers.

Giallongo S, Duminuco A, Dulcamare I, Zuppelli T, La Spina E, Scandura G, Santisi A, Romano A, Di Raimondo F, Tibullo D, Palumbo GA, Giallongo C. Giallongo S, et al. Among authors: giallongo c. Biomolecules. 2023 Nov 24;13(12):1701. doi: 10.3390/biom13121701. Biomolecules. 2023. PMID: 38136573 Free PMC article. Review.

74

ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis.

Duminuco A, Chifotides HT, Giallongo S, Giallongo C, Tibullo D, Palumbo GA. Duminuco A, et al. Among authors: giallongo s, giallongo c. Cancers (Basel). 2023 Dec 28;16(1):154. doi: 10.3390/cancers16010154. Cancers (Basel). 2023. PMID: 38201581 Free PMC article. Review.

75

Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis Patients.

Mangione R, Giallongo C, Duminuco A, La Spina E, Longhitano L, Giallongo S, Tibullo D, Lazzarino G, Saab MW, Sbriglione A, Palumbo GA, Graziani A, Alanazi AM, Di Pietro V, Tavazzi B, Amorini AM, Lazzarino G. Mangione R, et al. Among authors: giallongo c, giallongo s. Antioxidants (Basel). 2024 Apr 19;13(4):490. doi: 10.3390/antiox13040490. Antioxidants (Basel). 2024. PMID: 38671937 Free PMC article.

76

Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis.

D'Aprile S, Denaro S, Lavoro A, Candido S, Giallongo S, Torrisi F, Salvatorelli L, Lazzarino G, Amorini AM, Lazzarino G, Magro G, Tibullo D, Libra M, Giallongo C, Vicario N, Parenti R. D'Aprile S, et al. Among authors: giallongo c. Sci Rep. 2024 Sep 5;14(1):20770. doi: 10.1038/s41598-024-72024-8. Sci Rep. 2024. PMID: 39237744 Free PMC article.

77

Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis.

Spampinato M, Giallongo C, Giallongo S, Spina E, Duminuco A, Longhitano L, Caltabiano R, Salvatorelli L, Broggi G, Pricoco EP, Del Fabro V, Dulcamare I, DI Mauro AM, Romano A, Di Raimondo F, Li Volti G, Palumbo GA, Tibullo D. Spampinato M, et al. Among authors: giallongo c. J Transl Med. 2025 Jan 14;23(1):69. doi: 10.1186/s12967-025-06083-4. J Transl Med. 2025. PMID: 39810250 Free PMC article.

78

Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience.

Duminuco A, Bulla A, Rosso R, Romeo MA, Cambria D, La Spina E, Ximenes B, Giallongo C, Tibullo D, Romano A, Raimondo FD, Palumbo GA. Duminuco A, et al. Among authors: giallongo c. Vaccines (Basel). 2025 Jan 23;13(2):111. doi: 10.3390/vaccines13020111. Vaccines (Basel). 2025. PMID: 40006658 Free PMC article.

79

Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment.

D'Aprile S, Denaro S, Torrisi F, Longhitano L, Giallongo S, Giallongo C, Bontempi V, Bucolo C, Drago F, Mione MC, Li Volti G, Potokar M, Jorgačevski J, Zorec R, Tibullo D, Amorini AM, Vicario N, Parenti R. D'Aprile S, et al. Among authors: giallongo c. Cell Death Dis. 2025 Apr 24;16(1):336. doi: 10.1038/s41419-025-07667-0. Cell Death Dis. 2025. PMID: 40274776 Free PMC article.

80

Targeted metabolomic evaluation of peripheral blood mononucleated cells from patients with PMM2-CDG.

Mangione R, Cirnigliaro L, Saab MW, Pettinato F, Barbato A, Distefano A, Spina E, Lazzarino G, Volti GL, Longhitano L, Tibullo D, Pittalà A, Giallongo C, Di Pietro V, Tabbi G, Longo SA, Graziani A, Tavazzi B, Amorini AM, Lazzarino G, Barone R. Mangione R, et al. Among authors: giallongo c. Sci Rep. 2025 May 7;15(1):15929. doi: 10.1038/s41598-025-98846-8. Sci Rep. 2025. PMID: 40335571 Free PMC article.

81

Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma.

Cantafio MEG, Valentino I, Torcasio R, Ganino L, Veneziano C, Murfone P, Mesuraca M, Perrotta I, Tallarigo F, Agosti V, De Marco C, Pasqua T, Giallongo C, Cappello AR, Fiorillo M, Gentile M, Tibullo D, Viglietto G, Neri A, Amodio N. Cantafio MEG, et al. Among authors: giallongo c. Haematologica. 2025 Oct 1;110(10):2422-2435. doi: 10.3324/haematol.2025.287526. Epub 2025 May 22. Haematologica. 2025. PMID: 40400476 Free PMC article.

82

Electronic nicotine delivery systems exhibit reduced bronchial epithelial cells toxicity compared to cigarette: the Replica Project.

Caruso M, Emma R, Distefano A, Rust S, Poulas K, Zadjali F, Giordano A, Volarevic V, Mesiakaris K, Al Tobi M, Boffo S, Arsenijevic A, Zuccarello P, Giallongo C, Ferrante M, Polosa R, Li Volti G; Replica Project Group. Caruso M, et al. Among authors: giallongo c. Sci Rep. 2021 Dec 17;11(1):24182. doi: 10.1038/s41598-021-03310-y. Sci Rep. 2021. PMID: 34921164 Free PMC article.

83

Targeting Acetyl-CoA Carboxylase Suppresses De Novo Lipogenesis and Tumor Cell Growth in Multiple Myeloma.

Morelli E, Ribeiro CF, Rodrigues SD, Gao C, Socciarelli F, Maisano D, Favasuli V, Liu N, Todoerti K, Chakraborty C, Yao Y, Fulciniti M, Samur M, Aktas-Samur A, Amodio N, Turi M, Barello F, Penailillo J, Giallongo C, Romano A, Gulla A, Anderson KC, Inghirami G, Munshi NC, Loda M. Morelli E, et al. Among authors: giallongo c. Clin Cancer Res. 2025 May 15;31(10):1975-1987. doi: 10.1158/1078-0432.CCR-24-2000. Clin Cancer Res. 2025. PMID: 40053701 Free PMC article.

84

Pericytes in Microvessels: From "Mural" Function to Brain and Retina Regeneration.

Caporarello N, D'Angeli F, Cambria MT, Candido S, Giallongo C, Salmeri M, Lombardo C, Longo A, Giurdanella G, Anfuso CD, Lupo G. Caporarello N, et al. Among authors: giallongo c. Int J Mol Sci. 2019 Dec 17;20(24):6351. doi: 10.3390/ijms20246351. Int J Mol Sci. 2019. PMID: 31861092 Free PMC article. Review.

85

Uveal Melanoma Cells Elicit Retinal Pericyte Phenotypical and Biochemical Changes in an in Vitro Model of Coculture.

Anfuso CD, Longo A, Distefano A, Amorini AM, Salmeri M, Zanghì G, Giallongo C, Giurdanella G, Lupo G. Anfuso CD, et al. Among authors: giallongo c. Int J Mol Sci. 2020 Aug 3;21(15):5557. doi: 10.3390/ijms21155557. Int J Mol Sci. 2020. PMID: 32756477 Free PMC article.

86

Rebalancing Immune Interactions within the Brain-Spleen Axis Mitigates Neuroinflammation in an Aging Mouse Model of Alzheimer's Disease.

Cantone AF, Burgaletto C, Di Benedetto G, Gaudio G, Giallongo C, Caltabiano R, Broggi G, Bellanca CM, Cantarella G, Bernardini R. Cantone AF, et al. Among authors: giallongo c. J Neuroimmune Pharmacol. 2025 Feb 7;20(1):15. doi: 10.1007/s11481-025-10177-7. J Neuroimmune Pharmacol. 2025. PMID: 39918606 Free PMC article.

87

Immune responses to oligomeric α-synuclein in Parkinson's disease peripheral blood mononuclear cells.

Vega-Benedetti AF, Porcedda C, Ercoli T, Fusco G, Burgaletto C, Pillai R, Palmas F, Cantone AF, Angius F, Solla P, De Simone A, Cantarella G, Giallongo C, Sogos V, Defazio G, Carta AR. Vega-Benedetti AF, et al. Among authors: giallongo c. J Neurol. 2024 Sep;271(9):5916-5929. doi: 10.1007/s00415-024-12554-3. Epub 2024 Jul 10. J Neurol. 2024. PMID: 38985290 Free PMC article.

88

Pericytes and mesenchymal stromal cells converge toward pro-tumor phenotypes in the tumor microenvironment.

La Spina E, Giallongo C, Longhitano L, Ferrigno J, Di Rosa G, Del Fabro V, Calvo D, Giallongo S, Romano D, Duminuco A, Palumbo GA, Galvano F, Li Volti G, Barbagallo IA, Tibullo D. La Spina E, et al. Among authors: giallongo c. Discov Oncol. 2026 Mar 11. doi: 10.1007/s12672-026-04790-y. Online ahead of print. Discov Oncol. 2026. PMID: 41811593 Review.

89

Prothrombotic profiles in myelofibrosis: Fibrinogen oxidation and the beneficial effects of ruxolitinib.

Nencini F, La Spina E, Borghi S, Giurranna E, Argento FR, Fini E, Giallongo C, Duminuco A, Volti GL, Palumbo GA, Taddei N, Fiorillo C, Tibullo D, Becatti M. Nencini F, et al. Among authors: giallongo c. Thromb Res. 2025 Dec;256:109517. doi: 10.1016/j.thromres.2025.109517. Epub 2025 Oct 18. Thromb Res. 2025. PMID: 41135228 Free article.

90

MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes.

Giallongo C, Dulcamare I, Giallongo S, Duminuco A, Pieragostino D, Cufaro MC, Amorini AM, Lazzarino G, Romano A, Parrinello N, Di Rosa M, Broggi G, Caltabiano R, Caraglia M, Scrima M, Pasquale LS, Tathode MS, Li Volti G, Motterlini R, Di Raimondo F, Tibullo D, Palumbo GA. Giallongo C, et al. Among authors: giallongo s. Cell Death Dis. 2023 Oct 18;14(10):686. doi: 10.1038/s41419-023-06197-x. Cell Death Dis. 2023. PMID: 37852977 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters